Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
SES Solar Inc. (SESI)
Plan-les-Ouates, CH
SES Solar Inc. is a Swiss-based firm specializing in photovoltaic energy solutions. Its product portfolio includes versatile solar tiles, designed as standard panels suitable for installation on various roof types—flat or pitched—across both urban and rural environments. Additionally, SES Solar manufactures custom-engineered, architecturally integrated panels, often constructed from glass-glass or glass-tedlar, which serve multiple purposes: as building glazing, light-transmitting elements in industrial and residential structures, and as roofing for verandas. Beyond manufacturing, the company provides comprehensive project management, guiding installations from initial design through to completion. Furthermore, it offers ongoing monitoring, maintenance, and operational support for these systems. Established in 2001, SES Solar Inc. is headquartered in Plan-les-Ouates, Switzerland. Since November 23, 2010, it has operated as a subsidiary of Flannel Management Sàrl.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -99.80% | -96.55% | -99.98% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%-100.0% Q3'10: +10,677.8% (vs Q3'09)
-
EPS growth Drug Manufacturers - Specialty & Generic: +16.5%+98.8% ★ Q3'10: +1,100.0% (vs Q3'09)
-
FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%— Q3'10: +11.7% (vs Q3'09)
-
EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%— Q3'10: +28.5% (vs Q3'09)
-
ROIC Drug Manufacturers - Specialty & Generic: +6.5%-1,844.3% Q3'10: +38.1% (vs Q3'09)
-
Share dilution Drug Manufacturers - Specialty & Generic: +0.0%+0.1% Q3'10: 0.0% (vs Q3'09)
-
Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×1.39× Q3'10: 1.98× (vs Q3'09)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sandrine Crisafulli | Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer & Controller | 138.5K | female |
| Philippe Crisafulli | Chief Executive Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SESI
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
